Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Since 2020, COVID-19 has surged across the nation and the world. With variants like Omicron, Delta, Alpha and more, this ...

Concerns about COVID-19 have significantly diminished, but researchers continue to analyze its high transmission rate, aiming ...

LTV is more effective than NTV and ETV against Mpro mutants, making it a promising candidate for treating drug-resistant ...

From 11.7 percent to 23.4 percent of adults infected with the novel coronavirus experienced ... the virus during the outbreak of the Alpha and Delta variants in spring and summer 2021, 25 ...

Verywell Health's content is for informational and educational purposes only. Our website is not intended to be a substitute ...

Researchers at Kumamoto University have made a significant breakthrough in the fight against COVID-19 with the development of ...

The AHA has published a scientific statement regarding COVID-19-associated cardiac arrhythmias and autonomic dysfunction.

A clinical trial has found that Novavax’ COVID-19 vaccine is 86% protective against the UK variant of SARS-CoV-2, only slightly lower than the 96% efficacy seen with the original strain of the ...

With the acute phase of the Covid-19 pandemic fading even as the coronavirus persists and evolves, a new normal is taking shape around the world. Experts worry the unusual move, driven by vaccine ...

“To the sigmas of Australia,” she began, directing her address to an “oft-forgotten segment of our society” — the youngest cohorts of Australian citizens, Gen Z and Gen Alpha — “I ...